Crossmark

Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies

Crossref DOI link: https://doi.org/10.1016/j.gastre.2021.01.003

Published Print: 2021-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Calvet, Xavier

Carpio, Daniel

Rodríguez-Lago, Iago

García-Vicuña, Rosario

Barreiro-de-Acosta, Manuel

Juanola, Xavier

Aguas, Mariam

Castillo, Concepción

Gratacós, Jordi
License Information

Text and Data Mining valid from 2021-10-01

Version of Record valid from 2021-12-31
More Information

This article is maintained by: Elsevier

Article Title: Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2021.01.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.gastrohep.2021.01.007

Content Type: article

Copyright: © 2021 The Author(s). Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below